Added to YB: 2025-10-06
Pitch date: 2025-06-30
ONC [neutral]
BeOne Medicines AG
+29.49%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
Market Cap
$40.5B
Pitch Price
$150.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
108.94
P/E
625.64
EV/Sales
7.53
Sector
Biotechnology
Category
N/A
Show full summary:
Baird Chautauqua International and Global Growth Fund Portfolio Holding: BeOne Medicines AG
ONC (holding update): BeOne Medicines (formerly BeiGene) up 47% Q1 then down 11% Q2 on profit-taking & tariff concerns. Redomiciled to Switzerland in May. Achieved first GAAP & non-GAAP profits Q1, beat consensus, maintained FY25 guidance. Swiss biotech w/ strong momentum despite volatility.
Read full article (1 min)